A detailed history of Fedenia Advisers LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Fedenia Advisers LLC holds 6,746 shares of AZN stock, worth $477,346. This represents 0.26% of its overall portfolio holdings.

Number of Shares
6,746
Holding current value
$477,346
% of portfolio
0.26%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$63.2 - $79.58 $426,347 - $536,846
6,746 New
6,746 $442 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $219B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Fedenia Advisers LLC Portfolio

Follow Fedenia Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fedenia Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fedenia Advisers LLC with notifications on news.